ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy (2023)
Cunha, Juliana Pierobon Gomes da; Goncalves, Rodrigo ; Silva, Fernando; Aguiar, Fernando Nalesso; Mota, Bruna Salani ; Chequin, Bruna Bello; Soares Junior, Jose Maria ; Baracat, Edmund Chada ; Filassi, José Roberto
Source: Journal of clinical pathology. Unidade: FM
Subjects: PROGNÓSTICO, TERAPIA COMBINADA, NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Juliana Pierobon Gomes da et al. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy. Journal of clinical pathology. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/53967. Acesso em: 12 nov. 2024. , 2023
APA
Cunha, J. P. G. da, Goncalves, R., Silva, F., Aguiar, F. N., Mota, B. S., Chequin, B. B., et al. (2023). Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy. Journal of clinical pathology. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1136/jclinpath-2021-207771
NLM
Cunha JPG da, Goncalves R, Silva F, Aguiar FN, Mota BS, Chequin BB, Soares Junior JM, Baracat EC, Filassi JR. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy [Internet]. Journal of clinical pathology. 2023 ; 76( 4): 239-243.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53967
Vancouver
Cunha JPG da, Goncalves R, Silva F, Aguiar FN, Mota BS, Chequin BB, Soares Junior JM, Baracat EC, Filassi JR. Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy [Internet]. Journal of clinical pathology. 2023 ; 76( 4): 239-243.[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53967
Parte de monografia/livro
PET/CT no câncer de esôfago (2017)
Ono, Carla Rachel; Buchpiguel, Carlos Alberto; Sado, Heitor Naoki; Sapienza, Marcelo Tatit
Source: Tratado de radiologia. Unidade: FM
Subjects: NEOPLASIAS ESOFÁGICAS, DIAGNÓSTICO POR COMPUTADOR, PROGNÓSTICO, TERAPIA COMBINADA, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ONO, Carla Rachel et al. PET/CT no câncer de esôfago. Tratado de radiologia. Tradução . Barueri, SP: Manole, 2017. . . Acesso em: 12 nov. 2024.
APA
Ono, C. R., Buchpiguel, C. A., Sado, H. N., & Sapienza, M. T. (2017). PET/CT no câncer de esôfago. In Tratado de radiologia. Barueri, SP: Manole.
NLM
Ono CR, Buchpiguel CA, Sado HN, Sapienza MT. PET/CT no câncer de esôfago. In: Tratado de radiologia. Barueri, SP: Manole; 2017. [citado 2024 nov. 12 ]
Vancouver
Ono CR, Buchpiguel CA, Sado HN, Sapienza MT. PET/CT no câncer de esôfago. In: Tratado de radiologia. Barueri, SP: Manole; 2017. [citado 2024 nov. 12 ]
Artigo de periodico
Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma (2012)
Onuchic, Ana Claudia; Machado, Camila M. L.; Saito, Renata F.; Rios, Francisco J.; Jancar, Sonia ; Chammas, Roger
Source: Mediators of Inflammation. Unidade: FM
Subjects: WESTERN BLOTTING, CITOMETRIA DE FLUXO, ESTRESSE OXIDATIVO, FATOR DE ATIVAÇÃO DE PLAQUETAS, MELANOMA (QUIMIOTERAPIA), PROGNÓSTICO, TERAPIA COMBINADA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ONUCHIC, Ana Claudia et al. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma. Mediators of Inflammation, v. 2012, p. 1-6, 2012Tradução . . Disponível em: https://doi.org/10.1155/2012/175408. Acesso em: 12 nov. 2024.
APA
Onuchic, A. C., Machado, C. M. L., Saito, R. F., Rios, F. J., Jancar, S., & Chammas, R. (2012). Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma. Mediators of Inflammation, 2012, 1-6. doi:10.1155/2012/175408
NLM
Onuchic AC, Machado CML, Saito RF, Rios FJ, Jancar S, Chammas R. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma [Internet]. Mediators of Inflammation. 2012 ; 2012 1-6.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1155/2012/175408
Vancouver
Onuchic AC, Machado CML, Saito RF, Rios FJ, Jancar S, Chammas R. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma [Internet]. Mediators of Inflammation. 2012 ; 2012 1-6.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1155/2012/175408

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects